Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene's Treading Into Open Water
Motley Fool
Sunday, July 15, 2012 - 11:41am
tags:
Celgene
Can Eli Lilly Save This Drug?
Motley Fool
Sunday, July 15, 2012 - 11:40am
tags:
Eli Lilly, pomaglumetad methionil, schizophrenia
2 Pharma Companies Investors Should Avoid At Current Levels
Seeking Alpha
Sunday, July 15, 2012 - 11:39am
tags:
Ampio Pharmaceuticals, Dendreon
GSK in weekend talks to buy Human Genome: sources
Reuters
Sunday, July 15, 2012 - 11:37am
tags:
GSK, Human Genome Sciences, M&A
China Biotech In Review: Deals, Trials And Regulations
Seeking Alpha
Sunday, July 15, 2012 - 11:36am
tags:
Ascletis, Walvax Biotech, Fengmao Biotech, Siegfried Holding, Oculus Innovative Sciences
Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Seeking Alpha
Sunday, July 15, 2012 - 11:30am
tags:
Xoma, Jazz Pharmaceuticals, Pacific Biosciences, Amylin, Corcept Therapeutics, Santarus, Affymetrix, Ariad Pharmaceuticals, Amyris, Sequenom
3 Reasons to Buy Spectrum Pharmaceuticals
Motley Fool
Sunday, July 15, 2012 - 11:28am
tags:
Spectrum Pharmaceuticals
Why Incyte Could Be Headed Even Higher
Motley Fool
Sunday, July 15, 2012 - 11:27am
tags:
Incyte
Will the FDA Approve VIVUS' Obesity Drug?
Motley Fool
Sunday, July 15, 2012 - 11:25am
tags:
Vivus, obesity, weight loss, Qnexa
Buy Yourself Something Pretty
Motley Fool
Sunday, July 15, 2012 - 11:24am
tags:
Obagi Medical Products
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sunday, July 15, 2012 - 11:22am
tags:
Alkermes, Medivation, Cubist Pharmaceuticals, Ariad Pharmaceuticals, Questcor Pharmaceuticals, Arena Pharmaceuticals, Seattle Genetics, Incyte, United Therapeutics, Amarin, ONYX Pharmaceuticals, Pharmacyclics, Human Genome Sciences, Theravance
Ryan & Maniskas, LLP Files Class Action Lawsuit Against PolyMedix, Inc.
Yahoo/BusinessWire
Sunday, July 15, 2012 - 11:18am
tags:
PolyMedix
China may not produce for Big Pharma long-term
Fierce Pharma
Friday, July 13, 2012 - 2:48pm
tags:
China, Big Pharma
Questcor Falls After Failing To Quell Citron Concerns
Investors.com
Friday, July 13, 2012 - 2:47pm
tags:
Questcor, Acthar
Seattle Genetics CEO Says Drug Growth Path Means No Sale
Bloomberg
Friday, July 13, 2012 - 1:29pm
tags:
Seattle Genetics, M&A, Pharma CEOs, Clay Siegall
Questcor's Acthar Is One Hot Drug
Seeking Alpha
Friday, July 13, 2012 - 1:28pm
tags:
Acthar, Questcor, MS, multiple sclerosis
Icahn issues new warning to board of Forest Labs
Yahoo/Reuters
Friday, July 13, 2012 - 1:26pm
tags:
Forest Labs, Carl Icahn
Watson Pharmaceuticals subsidiary receives approval from FDA for ONE DOSE
The Fly on the Wall
Friday, July 13, 2012 - 1:25pm
tags:
Watson Pharmaceuticals, FDA, One Dose, One-Step, Teva Pharmaceuticals
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Friday, July 13, 2012 - 1:23pm
tags:
GSK, Amylin, AstraZeneca, Merck, Novartis, Pfizer
The Challenges in Staying #1 in Big Pharma
Forbes
Friday, July 13, 2012 - 1:22pm
tags:
Merck, Novartis, Pfizer, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.